Vanguard Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,424,048 shares of REGN stock, worth $5.36 Billion. This represents 0.08% of its overall portfolio holdings.

Number of Shares
9,424,048
Previous 9,407,891 0.17%
Holding current value
$5.36 Billion
Previous $5.97 Billion 17.08%
% of portfolio
0.08%
Previous 0.11%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$483.07 - $625.6 $7.8 Million - $10.1 Million
16,157 Added 0.17%
9,424,048 $4.95 Billion
Q1 2025

May 09, 2025
BUY
$634.14 - $744.83 $77.1 Million - $90.5 Million
121,545 Added 1.31%
9,407,891 $5.97 Billion
Q4 2024

Feb 11, 2025
SELL
$701.85 - $1046.91 $23.8 Million - $35.5 Million
-33,944 Reduced 0.36%
9,286,346 $6.61 Billion
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $334 Million - $392 Million
326,320 Added 3.63%
9,320,290 $9.8 Billion
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $56.3 Million - $68.3 Million
63,729 Added 0.71%
8,993,970 $9.45 Billion
Q1 2024

May 10, 2024
BUY
$902.69 - $993.35 $83 Million - $91.3 Million
91,956 Added 1.04%
8,930,241 $8.6 Billion
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $30.8 Million - $35.1 Million
39,780 Added 0.45%
8,838,285 $7.76 Billion
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $40.5 Million - $49.4 Million
-58,533 Reduced 0.66%
8,798,505 $7.24 Billion
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $3.44 Million - $4.08 Million
4,917 Added 0.06%
8,857,038 $6.36 Billion
Q1 2023

Jul 14, 2023
BUY
$680.49 - $826.97 $9,526 - $11,577
14 Added 0.0%
8,852,121 $7.27 Billion
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $88.2 Million - $107 Million
129,659 Added 1.49%
8,852,107 $7.27 Billion
Q4 2022

Feb 10, 2023
BUY
$705.89 - $766.39 $52.5 Million - $57 Million
74,323 Added 0.86%
8,722,448 $6.29 Billion
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $44.4 Million - $56 Million
77,380 Added 0.9%
8,648,125 $5.96 Billion
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $115 Million - $155 Million
210,415 Added 2.52%
8,570,745 $5.07 Billion
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $120 Million - $141 Million
201,815 Added 2.47%
8,360,330 $5.84 Billion
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $47.4 Million - $58.5 Million
87,234 Added 1.08%
8,158,515 $5.15 Billion
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $58.3 Million - $69.2 Million
101,621 Added 1.28%
8,071,281 $4.88 Billion
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $3.77 Billion - $4.45 Billion
7,969,660 New
7,969,660 $4.45 Billion

Others Institutions Holding REGN

# of Institutions
1,423
Shares Held
88.7M
Call Options Held
1.98M
Put Options Held
1.75M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $61B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email